Aurora Cannabis’ Revenue by End-Market (2017-2022)

This statistic highlights Aurora Cannabis’ Revenue by End-Market, reported on a quarterly basis from Q1 2017 onwards.

Aurora Cannabis is a leader in global Cannabis industry with around fifteen production facilities of which two are EU GMP certified. The dynamic growth strategy designed to attain large scale growth and long-term, sustainable profitability has enabled the company to capture greater margins across the cannabis industry value chain. The company derives its revenue from various market segments such as medical, consumer, counselling services, analytical trading services and others. As of Q3 2019, the revenues from the different cannabis related products came in at. And let’s look into Aurora Cannabis revenue by end market data here.

Aurora Cannabis Revenue by end-market:

For medical uses, the company provides products like dry flower or dried cannabis and cannabis extracts which includes oils and soft gels. The key to success in this segment is primarily low costs, patient capture, product innovation and branding through clinical trials. It contributes to nearly 37 per cent of the total revenue for Q3,2019 with a marginal 8 per cent increase as compared to Q2,2019.

(All figures in USD thousands, except percentages)

For consumer markets, the company provides products like vape pens, gel caps, infused beverages and edibles. Comprehensive product portfolio and heavy investments in R&D drive success in this segment. This market segment contributes to nearly 47 per cent of the total revenue for Q3,2019 with a significant increase (around 5061 per cent) as compared to Q2,2019.

Company Overview

Aurora Cannabis Inc., headquartered in Edmonton, is a Canadian licensed cannabis producer. The company is publicly trading on the Toronto Stock Exchange as ACB. The bulk of the company’s capacity is based in Canada with a growing international presence in markets like Denmark and Latin America.

ACB is the second largest cannabis producing company in the world in terms of market capitalization, after Canopy Growth Corporation. Today, it is growing company with over fifteen strategic acquisitions since August,2016.

The company operates on a mass scale, high tech production model to meet the growing cannabis demand in the medical and consumer markets. They have a sustainable, low cost advantage driven by their extensive use of automation techniques for production. The company is motivated to invest extensively in Research and Development (R&D) activities to create optionality and high-margin products with an intent to drive both near-term and medium-term profitability.

Did you like Aurora Cannabis’ Revenue by End-Market statistic?

Access more such KPI data points and segment financials on thousands of US stocks, with Business Quant.

You can get started here.